
    
      This multicentre, single arm post-market clinical study aims to collect medical information
      on patients implanted with PuraStat®, Absorbable Haemostatic Material, according to each
      participating institution's procedures and standards of care for confirming the safety and
      the performance of PuraStat®, for the management of bleeding in vascular surgery (Carotid
      Endarterectomy either by direct closure (without the use of patch), or by patch
      reconstruction or eversion technique).
    
  